pH/Glutathione (GSH) Co-triggered Degradable Polyprodrug as Drug Self-delivery System for Tumor-specific Doxorubicin Delivery: Effect of Aggregation States
RAPID COMMUNICATION|Updated:2025-07-26
|
pH/Glutathione (GSH) Co-triggered Degradable Polyprodrug as Drug Self-delivery System for Tumor-specific Doxorubicin Delivery: Effect of Aggregation States
pH/Glutathione (GSH) Co-triggered Degradable Polyprodrug as Drug Self-delivery System for Tumor-specific Doxorubicin Delivery: Effect of Aggregation States
高分子科学(英文)2025年43卷第8期 页码:1277-1283
Affiliations:
State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China
Author bio:
pliu@lzu.edu.cn
Funds:
Electronic supplementary information (ESI) is available free of charge in the online version of this article at http://doi.org/10.1007/s10118-025-3340-8.
Yang, C.; Liu, P. pH/Glutathione (GSH) co-triggered degradable polyprodrug as drug self-delivery system for tumor-specific doxorubicin delivery: effect of aggregation states. Chinese J. Polym. Sci. 2025, 43, 1277–1283
Chen Yang, Peng Liu. pH/Glutathione (GSH) Co-triggered Degradable Polyprodrug as Drug Self-delivery System for Tumor-specific Doxorubicin Delivery: Effect of Aggregation States[J]. Chinese Journal of Polymer Science, 2025, 43(8): 1277-1283.
Yang, C.; Liu, P. pH/Glutathione (GSH) co-triggered degradable polyprodrug as drug self-delivery system for tumor-specific doxorubicin delivery: effect of aggregation states. Chinese J. Polym. Sci. 2025, 43, 1277–1283DOI: 10.1007/s10118-025-3340-8.
Chen Yang, Peng Liu. pH/Glutathione (GSH) Co-triggered Degradable Polyprodrug as Drug Self-delivery System for Tumor-specific Doxorubicin Delivery: Effect of Aggregation States[J]. Chinese Journal of Polymer Science, 2025, 43(8): 1277-1283.DOI: 10.1007/s10118-025-3340-8.
pH/Glutathione (GSH) Co-triggered Degradable Polyprodrug as Drug Self-delivery System for Tumor-specific Doxorubicin Delivery: Effect of Aggregation States
The effect of the aggregation states of the pH/GSH co-triggered degradable polyprodrug on its tumor intracellular microenvironment (TME)-triggered drug release was investigated
by fabricating nanomedicines via fast precipitation and slow self-assembly. It is expected to be a secondary strategy for improved TME-responsive drug delivery in tumor chemotherapy
in addition to the molecular structures of the polyprodrugs as drug self-delivery systems (DSDSs).
Abstract
Numerous efforts have been devoted to altering the dynamic covalent linkers between the drug structural units in polyprodrugs from the viewpoint of molecular structure; however
the effect of their aggregation states has not yet been explored. Here
the effect of aggregation states on the
in vitro
drug release and cytotoxicity was investigated using a pH/glutathione (GSH) co-triggered degradable doxorubicin (DOX)-based polyprodrug (PDOX) as a model
which was synthesized by the facile polymerization of a pH/GSH dual-triggered dimeric prodrug (DDOX
ss
) and 2
2-dimethoxypropane (DMP) by forming acid-labile ketal bond. Owing to the pH/GSH dual-triggered disulfide/
α
-amide and acid-labile ketal linkers between the DOX structural units
the resultant PDOX exhibited excellent pH/GSH co-triggered DOX release. With a similar diameter
the PDOX-NPs1 nanomedicines
via
fast precipitation showed faster DOX release than PDOX-NPs2
via
slow self-assembly
regardless of their polymerization degree (DP). The effect of aggregation states is expected to be a secondary strategy for a more desired tumor intracellular microenvironment-responsive drug delivery for tumor chemotherapy
in addition to the molecular structures of polyprodrugs as drug self-delivery systems (DSDSs).
关键词
Keywords
references
Alex, J.; Weber, C.; Guerrero-Sanchez, C.; Schubert, U. S. Recent developments in synthetic approaches for macromolecular prodrugs. Prog. Polym. Sci. 2024 , 155 , 101855..
Girase, M. L.; Patil, P. G.; Ige, P. P. Polymer-drug conjugates as nanomedicine: a review. Int. J. Polym. Mater. Polym. Biomater. 2020 , 69 , 990−1014..
Qin, S. Y.; Zhang, A. Q.; Cheng, S. X.; Rong, L.; Zhang, X. Z. Drug self-delivery systems for cancer therapy. Biomaterials 2017 , 112 , 234−247..
Liu, P. Polyprodrugs for tumor chemotherapy: from molecular structure to drug release performance. J. Mater. Chem. B 2023 , 11 , 9565−9571..
Lin, C.; Liang, Y. X.; Guo, M. Y.; Saw, P. E.; Xu, X. D. Stimuli-responsiv e polyprodrug for cancer therapy. Mater. Today Adv. 2022 , 15 , 100266..
Li, X. M.; Liu, P. Synthesis and self-assembly of an acid/reduction co-triggered degradable amphiphilic copolyprodrug as a tumor-selective drug self-delivery system. J. Mater. Chem. B 2022 , 10 , 2926−2932..
Li, X.M.; Zhang, J.; Liu, P. Facile one-pot synthesis of amphiphilic acid/hypoxia co-triggered degradable diblock polyprodrug for tumor selective drug delivery. Int. J. Pharm. 2021 , 606 , 120941..
Li, J. G.; Liu, P. pH/Reduction dual-triggered degradable poly(doxorubicin) prodrug nanoparticles for leakage-free tumor-specific self-delivery. Macromol. Rapid Commun . 2018 , 39 , 1800381..
Yang, C.; Liu, P. Disulffde/ α -amide-bridged doxorubicin dimeric prodrug: effect of aggregation structures on pH/GSH dual-triggered drug release. Langmuir 2024 , 40 , 11098−11105..
Yang, C.; Liu, P. Regulating drug release performance of acid-triggered dimeric prodrug- based drug self-delivery system by altering its aggregation structure. Molecules 2024 , 29 , 3619..
Yang, C.; Liu, P. Structural aspects of dimeric prodrug-based carrier-free nanomedicines for tumor chemotherapy. J. Mater. Chem. B 2025 , 13 , 3292−3294..
Gillies, E. R.; Frechet, J. M. J. pH-Responsive copolymer assemblies for controlled release of doxorubicin. Bioconjugate Chem . 2005 , 16 , 361–368..
Missirlis, D.; Kawamura, R.; Tirelli, N.; Hubbell, J. A. Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur. J. Pharm. Sci. 2006 , 29 , 120−129..
Zhang, P.; Li, J.; Ghazwani, M.; Zhao, W. C.; Huang, Y. X.; Zhang, X. L.; Venkataramanan, R.; Li, S. Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy. Biomaterials 2015 , 67 , 104−114..
Lee, J.; Kim, J.; Lee, Y. M.; Park, D.; Im, S.; Song, E. H.; Park, H.; Kim, W. J. Self-assembled nanocomplex between polymerized phenylboronic acid and doxorubicin for efficient tumor-targeted chemotherapy. Acta Pharm. Sin . 2017 , 38 , 848–858..
Li, J.; Yang, C.; Zhou, P. P.; Liu, P. Effect of aggregation structures of dimeric prodrug-based carrier-free nanomedicines for tumor chemotherapy. Colloid Surf. A-Physicochem. Eng. Aspects 2024 , 693 , 134044..
Wang, T.; Jin, M.; Chen, Z. L.; Hu, X. J.; Pu, L.; Pei, Z. C.; Pei, Y. X. Tumor microenvironment responsive supramolecular glyco-nanovesicles based on diselenium-bridged pillar[5 ] arene dimer for targeted chemotherapy. Chem. Commun. 2020 , 56 , 10642−10645..
Zhao, X. M.; Liu, P. Synthesis of amphiphilic pH-responsive doxorubicin and ferrocene-containing copolyprodrug as drug self-delivery system and its in vitro synergistic apoptosis and ferroptosis tumor therapy. Chinese J. Polym. Sci. 2025 , 43 , 730−737..
Huang, Y. K.; Tian, H.-R.; Zhang, M. Z.; He, J. L.; Liu, J.; Ni, P. H. Monoclonal antibody-conjugated polyphosphoester-hyd-DOX prodrug nanoparticles for targeted chemotherapy of liver cancer cells. Chinese J. Polym. Sci. 2021 , 39 , 1392−1402..
The trial reading is over, you can activate your VIP account to continue reading.
Synthesis of Amphiphilic pH-Responsive Doxorubicin and Ferrocene-containing Copolyprodrug as Drug Self-delivery System and Its In Vitro Synergistic Apoptosis and Ferroptosis Tumor Therapy
Tumor-Penetrating and Mitochondria-Targeted Drug Delivery Overcomes Doxorubicin Resistance in Lung Cancer
Manipulating Hierarchical Aggregation Structure via Film-forming Kinetics Enables Organic Photovoltaics over 20% Efficiency
Topology-regulated Co-assembly of Single Chain Polymer Nanoparticles and Block Copolymers into Hierarchical Micelle@Vesicle Composite Structures
Preparation and Chiral Recognition Ability of Crystalline Cellulose Phenylcarbamate
相关作者
Xiao-Mei Zhao
Meng-Xue Zhou
Jia-Yu Zhang
Xiao-Meng Cai
Rui Dou
Li-Fo Ruan
Wen-Chu Lin
Jun Chen
相关机构
High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China, University of Science and Technology of China
Division of Nuclear Technology and Applications, Institute of High Energy Physics, Chinese Academy of Sciences (CAS)
Key Laboratory of Tea Biology and Resource Utilization of Ministry of Agriculture, Tea Research Institute, Chinese Academy of Agricultural Sciences
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics and University of Chinese Academy of Sciences (UCAS), Chinese Academy of Sciences (CAS)
School of Biomedical Engineering, Sun Yat-sen University